Product Code: BIO119B
Highlights:
The global market for synthetic biology is expected to increase from $35.5 billion in 2023 to $59.2 billion by the end of 2028, with a compound annual growth rate (CAGR) of 10.8% during the forecast period of 2023-2028.
Enabled Products market for synthetic biology is expected to increase from $32.8 billion in 2023 to $55.2 billion by the end of 2028, with a CAGR of 11.0% during the forecast period of 2023-2028.
Biological Components market for synthetic biology is expected to increase from $1.1 billion in 2023 to $1.6 billion by the end of 2028, with a CAGR of 8.0% during the forecast period of 2023-2028.
Report Scope:
The report is designed to be a comprehensive business tool to report focuses on 10 selected synthetic biology companies and the key areas in the field driving the industry growth that allows these companies to succeed.
The market is divided into segments and by application/industry as follows -
By product -
- Enabling Products.
- Biologic Components.
- Integrated systems
- Enabled Products.
By Industry -
- R&D Tools.
- Diagnostics/Pharmaceuticals.
- Agriculture.
- Chemicals.
- Energy.
- Food & Beverages.
- Others.
Each area is covered in detail, identifying current products in the market in the base year 2022, measuring current market size and identifying current and potential market drivers, forecasting for 2028, assessing current and potential competitors, and identifying current competitor market shares for the base year of 2022.
Report Includes:
- 141 data tables and 33 additional tables
- An overview of the top 10 suppliers of synthetic biology technology and the global market
- Analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, forecasts for 2028, and projections of compound annual growth rates (CAGRs) through 2028
- Evaluation of the current market size and revenue growth prospects specific to synthetic biology technology, accompanied by a market share analysis by test type, industry and geographic region
- Coverage of evolving technologies, the current and future market potential, and the regulatory framework and reimbursement scenarios
- Review of patents, the product pipeline and ESG trends related to the synthetic biology industry
- Market share analysis of the key companies and coverage of mergers & acquisitions, joint ventures, collaborations, partnerships and other market strategies
- Company profiles of major players within the industry, including Amyris Inc., Beyond Meat Inc., GenScript, Ginkgo Bioworks, Novozymes A/S, and Twist Biosciences.
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- What's New in this Update?
- Methodology
- Information Source
- Geographic Breakdown
- Segmentation Breakdown
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
- History
- Technology
- Market Overview
Chapter 4 Market Dynamics
- Market Dynamics
- Drivers
- Opportunities
- Restraints
Chapter 5 Emerging Trends/Technologies in the Synthetic Biology Market
- Overview
- Prime Editing
- AI in Synthetic Biology
- DNA Data Storage
- Do-it-yourself Synthetic Biology Community
Chapter 6 Sustainability in Synthetic Biology Market: An ESG Perspective
- Introduction
- Environmental Factors
- Social Factors
- Governance Factors
- Synthetic Biology Market ESG Performance Analysis by Company
- Amyris ESG Performance
- Novozymes ESG Performance
- Thermofisher, ESG Performance
- Consumer Attitude Towards ESG in the Synthetic Biology Market
- Conclusion
Chapter 7 Global Market of Synthetic Biology
- World Demand for Synthetic Biology
Chapter 8 Market Breakdown by Product Type
- Introduction
- Enabling Products Market
- North America
- Latin America
- Europe
- Asia-Pacific
- Rest of the World
- Biological Components Market
- North America
- Latin America
- Europe
- Asia-Pacific
- Rest of the World
- Integrated Systems Market
- North America
- Latin America
- Europe
- Asia-Pacific
- Rest of the World
- Enabled Products Market
- North America
- Latin America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 9 Market Breakdown by Industry
- Introduction
- R&D Tools
- North America
- Latin America
- Europe
- Asia-Pacific
- Rest of the World
- Diagnostics/Pharmaceuticals. Market
- North America
- Latin America
- Europe
- Asia-Pacific
- Rest of the World
- Agriculture Market
- North America
- Latin America
- Europe
- Asia-Pacific
- Chemicals Industry
- North America
- Latin America
- Europe
- Asia-Pacific
- Rest of the World
- Energy Industry
- North America
- Latin America
- Europe
- Asia-Pacific
- Rest of the World
- Food & Beverages Market
- North America
- Latin America
- Europe
- Asia-Pacific
- Rest of the World
- Synthetic Biology in Other End Uses
- North America
- Latin America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 10 Competitive Landscape
- Industry Scenario
- Company Shares
- Competitive Landscape by Application
- R&D Tools Industry
- Diagnostic and Pharmaceuticals Industry
- Agriculture Industry
- Energy Industry
- Chemicals Industry
- Food & Beverages Industry
Chapter 11 Patents
- Patent Analysis by Manufacturer
Chapter 12 Company Profiles
- AGILENT TECHNOLOGIES INC.
- AMYRIS INC.
- BEYOND MEAT INC.
- CODEXIS INC.
- CROPENERGIES AG
- DSM
- GENSCRIPT
- GILEAD SCIENCES INC.
- GINKGO BIOWORKS
- NOVARTIS PHARMA AG
- NOVOZYMES A/S
- THERMO FISHER SCIENTIFIC INC.
- TWIST BIOSCIENCE
- VERBIO VEREINIGTE BIOENERGIE AG
Chapter 13 Appendix: Acronyms